Replies to post #18 on Cadrenal Therapeutics Inc (CVKD)

[oldstocks]

Cadrenal Therapeutics Provides Third Quarter 2023 Corporate Update

https://finance.yahoo.com/news/cadrenal-therapeutics-provides-third-quarter-140000695.html

PONTE VEDRA, Fla., Nov. 9, 2023 /PRNewswire/ -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) ("Cadrenal Therapeutics" or the "Company") a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths due to blood clots in patients with certain rare medical conditions, today provided a corporate update in connection with the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023.